Role of Milrinone in the Prevention of Septic Myocardial Dysfunction in Pediatric Severe Sepsis and Septic Shock

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202302881132303

Enrollment

Registered

2023-02-22

Start date

2023-02-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatrics Cardiology

Interventions

Milrinone

Survival Sepsis Campaign

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Children with severe sepsis/septic shock after resuscitation according to pediatric 2020 surviving sepsis campaign international guidelines( SSC) - Children with a cardiac index of more than 2.2 l/min/m2.

Exclusion criteria

Exclusion criteria: - Patients with primary myocardial diseases or congenital heart or chronic heart disease. - Patients with significant left ventricular outflow tract obstruction or the need for extracorporeal membrane oxygenation. - Patients receiving chemotherapeutic agents.

Design outcomes

Primary

Measure	Time frame
Development of low cardiac output syndrome ;Death	—

Secondary

Measure	Time frame
Duration of Pediatric Intensive Care Unit stay ;Duration of mechanical ventilation	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026